Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer

Open access
Zhou, Peipei, Shi, Hao, Huang, Hongling, Sun, Xiang, Yuan, Sujing, Chapman, Nicole M., Connelly, Jon P., Lim, Seon Ah, Saravia, Jordy, KC, Anil, Pruett-Miller, Shondra M., Chi, Hongbo · 2023 · Nature

Abstract

CD8+ cytotoxic T cells (CTLs) orchestrate antitumour immunity and exhibit inherent heterogeneity 1,2, with precursor exhausted T (T pex) cells but not terminally exhausted T (T ex) cells capable of responding to existing immunotherapies 3–7. The gene regulatory network that underlies CTL differentiation and whether T ex cell responses can be functionally reinvigorated are incompletely understood. Here we systematically mapped causal gene regulatory networks using single-cell CRISPR screens in vivo and discovered checkpoints for CTL differentiation. First, the exit from quiescence of T pex cells initiated successive differentiation into intermediate T ex cells. This process is differentially regulated by IKAROS and ETS1, the deficiencies of which dampened and increased mTORC1-associated metabolic activities, respectively. IKAROS-deficient cells accumulated as a metabolically quiescent T pex cell population with limited differentiation potential following immune checkpoint blockade (ICB). Conversely, targeting ETS1 improved antitumour immunity and ICB efficacy by boosting differentiation of T pex to intermediate T ex cells and metabolic rewiring. Mechanistically, TCF-1 and BATF are the targets for IKAROS and ETS1, respectively. Second, the RBPJ–IRF1 axis promoted differentiation of intermediate T ex to terminal T ex cells. Accordingly, targeting RBPJ enhanced functional and epigenetic reprogramming of T ex cells towards the proliferative state and improved therapeutic effects and ICB efficacy. Collectively, our study reveals that promoting the exit from quiescence of T pex cells and enriching the proliferative T ex cell state act as key modalities for antitumour effects and provides a systemic framework to integrate cell fate regulomes and reprogrammable functional determinants for cancer immunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-023-06733-x

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 175

Metadata

Authors
Zhou, P., Shi, H., Huang, H., Sun, X., Yuan, S., Chapman, N. M., Connelly, J. P., Lim, S. A., Saravia, J., KC, A., Pruett-Miller, S. M., & Chi, H.
Venue
Nature
Published
2023-11-15
Volume
624
Issue
7990
Pages
154-163
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4388694182
Cited by
175
References
33
FWCI
18.12
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer. https://app.cochat.ai/papers/10.1038/s41586-023-06733-x
The paper
Zhou, P., Shi, H., Huang, H., Sun, X., Yuan, S., Chapman, N. M., Connelly, J. P., Lim, S. A., Saravia, J., KC, A., Pruett-Miller, S. M., & Chi, H. (2023). Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer. Nature. https://doi.org/10.1038/s41586-023-06733-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.